THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Lauren Dockery to Clinical Trials, Phase I as Topic

Back to Details
This is a "connection" page, showing publications Lauren Dockery has written about Clinical Trials, Phase I as Topic.
Lauren Dockery
Connection Strength
0.146
Clinical Trials, Phase I as Topic
  1. Tolerance and toxicity of the PARP inhibitor olaparib in older women with epithelial ovarian cancer. Gynecol Oncol. 2017 12; 147(3):509-513.
    View in: PubMed
    Score: 0.146
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES